Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors

被引:33
作者
Li, Juanjuan [1 ]
Li, Yang [1 ]
Yang, Dan [1 ]
Hu, Nan [1 ]
Guo, Zhanling [1 ]
Kuang, Chunxiang [2 ]
Yang, Qing [1 ,3 ]
机构
[1] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Songhu Rd 2005, Shanghai 200438, Peoples R China
[2] Tongji Univ, Dept Chem, Siping Rd 1239, Shanghai 200092, Peoples R China
[3] East China Univ Sci & Technol, SCICB, 130 Meilong Rd, Shanghai 200237, Peoples R China
基金
高等学校博士学科点专项科研基金; 中国国家自然科学基金;
关键词
Indoleamine; 2; 3-dioxygenase; IDO2 bioassay system; IDO2; inhibitor; Tryptanthrin derivatives; TRYPTOPHAN DEGRADATION; QUINOLINIC ACID; 2,3-DIOXYGENASE; IDO2; ENZYME; EXPRESSION; PURIFICATION; METABOLISM; DISTINCT; TARGET;
D O I
10.1016/j.ejmech.2016.07.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As an analogue of IDO1 (indoleamine 2, 3-dioxygenase 1), the well-known new therapeutic target, IDO2 is receiving increased attention. Herein, the expression and purification of recombinant human IDO2 (hIDO2) and the establishment of a hIDO2 bioassay system on both enzymatic and cellular levels are described. Nine tryptanthrin derivatives were screened for potential hIDO2 inhibitory activities, and their Ki values, enzymatic and cellular IC50 values, as well as the types of inhibition were measured. The typtanthrin derivatives 5i, 5c and 5d (especially 5i) were found to be potent hIDO2 inhibitors with superior efficiency far better than that of the most frequently-used inhibitor L-1-MT. Two ultimate purposes of the present study have been achieved: establishing an IDO2 bioassay system and screening novel IDO2 inhibitors that can be used (directly or with some modifications) for potential therapeutic applications. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 42 条
[1]   Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties [J].
Austin, Christopher J. D. ;
Astelbauer, Florian ;
Kosim-Satyaputra, Priambudi ;
Ball, Helen J. ;
Willows, Robert D. ;
Jamie, Joanne F. ;
Hunt, Nicholas H. .
AMINO ACIDS, 2009, 36 (01) :99-106
[2]   Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2 [J].
Austin, Christopher Jonathan Daraius ;
Mailu, B. M. ;
Maghzal, G. J. ;
Sanchez-Perez, A. ;
Rahlfs, S. ;
Zocher, K. ;
Yuasa, H. J. ;
Arthur, J. W. ;
Becker, K. ;
Stocker, R. ;
Hunt, N. H. ;
Ball, H. J. .
AMINO ACIDS, 2010, 39 (02) :565-578
[3]   Optimised expression and purification of recombinant human indoleamine 2,3-dioxygenase [J].
Austin, CJD ;
Mizdrak, J ;
Matin, A ;
Sirijovski, N ;
Kosim-Satyaputra, P ;
Willows, RD ;
Roberts, TH ;
Truscott, RJW ;
Polekhina, G ;
Parker, MW ;
Jamie, JF .
PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (02) :392-398
[4]   Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2 [J].
Bakmiwewa, Supun M. ;
Fatokun, Amos A. ;
Anh Tran ;
Payne, Richard J. ;
Hunt, Nicholas H. ;
Ball, Helen J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) :7641-7646
[5]   Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway [J].
Ball, Helen J. ;
Yuasa, Hajime J. ;
Austin, Christopher J. D. ;
Weiser, Silvia ;
Hunt, Nicholas H. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (03) :467-471
[6]   Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice [J].
Ball, Helen J. ;
Sanchez-Perez, Angeles ;
Weiser, Silvia ;
Austin, Christopher J. D. ;
Astelbauer, Florian ;
Miu, Jenny ;
McQuillan, James A. ;
Stocker, Roland ;
Jermiin, Lars S. ;
Hunt, Nicholas H. .
GENE, 2007, 396 (01) :203-213
[7]   Human tryptophan dioxygenase: A comparison to indoleamine 2,3-dioxygenase [J].
Batabyal, Dipanwita ;
Yeh, Syun-Ru .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (50) :15690-15701
[8]   Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial [J].
Eldredge, Harriet B. ;
DeNittis, Albert ;
DuHadaway, James B. ;
Chernick, Michael ;
Metz, Richard ;
Prendergast, George C. .
JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (03) :315-321
[9]   Signaling defects in anti-tumor T cells [J].
Frey, Alan B. ;
Monu, Ngozi .
IMMUNOLOGICAL REVIEWS, 2008, 222 :192-205
[10]   Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue [J].
Hansen, AM ;
Driussi, C ;
Turner, V ;
Takikawa, O ;
Hunt, NH .
REDOX REPORT, 2000, 5 (2-3) :112-115